Application of optical coherence tomography in percutaneous coronary intervention.
暂无分享,去创建一个
Takashi Akasaka | Takashi Kubo | T. Akasaka | T. Kubo | Y. Ino | A. Tanaka | Atsushi Tanaka | Hironori Kitabata | Takashi Tanimoto | H. Kitabata | T. Tanimoto | Yasushi Ino
[1] P. Serruys,et al. Quantitative ex vivo and in vivo comparison of lumen dimensions measured by optical coherence tomography and intravascular ultrasound in human coronary arteries. , 2009, Revista espanola de cardiologia.
[2] Joanna J Wykrzykowska,et al. First-in-man evaluation of intravascular optical frequency domain imaging (OFDI) of Terumo: a comparison with intravascular ultrasound and quantitative coronary angiography. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[3] Takeshi Kimura,et al. Incidence, Risk Factors, and Clinical Sequelae of Angiographic Peri-Stent Contrast Staining After Sirolimus-Eluting Stent Implantation , 2011, Circulation.
[4] StéphaneCook,et al. Incomplete Stent Apposition and Very Late Stent Thrombosis After Drug-Eluting Stent Implantation , 2007 .
[5] G. Guagliumi,et al. Impact of different stent alloys on human vascular response to everolimus‐eluting stent: An optical coherence tomography study: The OCTEVEREST , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[6] Eiji Toyota,et al. Visualization of neointima formation by optical coherence tomography. , 2005, International heart journal.
[7] B X Chen,et al. Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography , 2007, Heart.
[8] Hiroto Tsujioka,et al. Assessment by optical coherence tomography of stent struts across side branch. -Comparison of bare-metal stents and drug-elution stents.-. , 2011, Circulation journal : official journal of the Japanese Circulation Society.
[9] Hiram G Bezerra,et al. Angiographic, IVUS and OCT evaluation of the long-term impact of coronary disease severity at the site of overlapping drug-eluting and bare metal stents: a substudy of the ODESSA trial , 2010, Heart.
[10] G. Guagliumi,et al. Impact of drug release kinetics on vascular response to different zotarolimus-eluting stents implanted in patients with long coronary stenoses: the LongOCT study (Optical Coherence Tomography in Long Lesions). , 2011, JACC. Cardiovascular interventions.
[11] Hiram G. Bezerra,et al. Plaque and thrombus evaluation by optical coherence tomography , 2011, The International Journal of Cardiovascular Imaging.
[12] M. Takano,et al. Six-month follow-up evaluation for everolimus-eluting stents by intracoronary optical coherence tomography: comparison with paclitaxel-eluting stents. , 2013, International journal of cardiology.
[13] P. Serruys,et al. In vivo validation of a novel three-dimensional quantitative coronary angiography system (CardiOp-B): comparison with a conventional two-dimensional system (CAAS II) and with special reference to optical coherence tomography. , 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[14] A. Rollins,et al. Intracoronary optical coherence tomography: a comprehensive review clinical and research applications. , 2009, JACC. Cardiovascular interventions.
[15] Giuseppe Biondi-Zoccai,et al. Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging. , 2012, JACC. Cardiovascular interventions.
[16] Gijs van Soest,et al. Optical coherence tomography patterns of stent restenosis. , 2009, American heart journal.
[17] Hiroyuki Okura,et al. Frequency and spatial distribution of thin-cap fibroatheroma assessed by 3-vessel intravascular ultrasound and optical coherence tomography: an ex vivo validation and an initial in vivo feasibility study. , 2009, Circulation journal : official journal of the Japanese Circulation Society.
[18] E. Halpern,et al. Characterization of Human Atherosclerosis by Optical Coherence Tomography , 2002, Circulation.
[19] Patrick W Serruys,et al. Three-dimensional optical frequency domain imaging in conventional percutaneous coronary intervention: the potential for clinical application. , 2013, European heart journal.
[20] Takashi Akasaka,et al. Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study. , 2008, JACC. Cardiovascular imaging.
[21] T. Akasaka,et al. Effect of strut thickness on neointimal atherosclerotic change over an extended follow-up period (≥ 4 years) after bare-metal stent implantation: intracoronary optical coherence tomography examination. , 2012, American heart journal.
[22] Takashi Akasaka,et al. Identification of Vulnerable Plaques with Optical Coherence Tomography , 2011 .
[23] Hiroto Tsujioka,et al. Advantage of next‐generation frequency‐domain optical coherence tomography compared with conventional time‐domain system in the assessment of coronary lesion , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[24] Seung‐Jung Park,et al. Optical Coherence Tomographic Analysis of In-Stent Neoatherosclerosis After Drug–Eluting Stent Implantation , 2011, Circulation.
[25] R. Virmani,et al. Pathological Correlates of Late Drug-Eluting Stent Thrombosis: Strut Coverage as a Marker of Endothelialization , 2007, Circulation.
[26] Hiroto Tsujioka,et al. Comparison of contrast media and low-molecular-weight dextran for frequency-domain optical coherence tomography. , 2012, Circulation journal : official journal of the Japanese Circulation Society.
[27] Yoshihiko Seino,et al. Appearance of lipid-laden intima and neovascularization after implantation of bare-metal stents extended late-phase observation by intracoronary optical coherence tomography. , 2009, Journal of the American College of Cardiology.
[28] T. Akasaka,et al. Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study. , 2009, European heart journal.
[29] Takashi Akasaka,et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. , 2007, Journal of the American College of Cardiology.
[30] T. Akasaka,et al. Optical Coherence Tomography , 2012 .
[31] D. Ramsdale,et al. Chronic total occlusions—a stiff challenge requiring a major breakthrough: is there light at the end of the tunnel? , 2005, Heart.
[32] Yoshinobu Onuma,et al. Relation between plaque type and dissections at the edges after stent implantation: an optical coherence tomography study. , 2011, International journal of cardiology.
[33] Hiromasa Otake,et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. , 2007, European heart journal.
[34] Y. Iesaka,et al. Impact of Coronary Plaque Morphology Assessed by Optical Coherence Tomography on Cardiac Troponin Elevation in Patients With Elective Stent Implantation , 2011, Circulation. Cardiovascular interventions.
[35] T. Kawamoto,et al. Natural history of stent edge dissection, tissue protrusion and incomplete stent apposition detectable only on optical coherence tomography after stent implantation – preliminary observation – . , 2012, Circulation journal : official journal of the Japanese Circulation Society.
[36] T. Akasaka,et al. Thin-Cap Fibroatheroma as High-Risk Plaque for Microvascular Obstruction in Patients With Acute Coronary Syndrome , 2011, Circulation. Cardiovascular imaging.
[37] T. Akasaka,et al. Impact of Hinge Motion on In-Stent Restenosis After Sirolimus-Eluting Stent Implantation , 2011 .
[38] Michael Joner,et al. Vascular Responses to Drug Eluting Stents: Importance of Delayed Healing , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[39] T. Akasaka. What can we expect in PCI in patients with chronic coronary artery disease. - Indication of PCI for angiographically significant coronary artery stenosis without objective evidence of myocardial ischemia (Con)-. , 2011, Circulation journal : official journal of the Japanese Circulation Society.